Page last updated: 2024-11-01

nifedipine and Bladder Cancer

nifedipine has been researched along with Bladder Cancer in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Fourteen human cancer cell lines with and without DNA MMR derived from carcinomas of the colon, bladder, ovary and prostate were treated with CAI, vehicle or control drugs (nifedipine and 5-flurouracil)."1.35Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency. ( Friedlander, ML; Kohn, EC; Qu, XJ; Yang, JL; Yu, Y, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, JL1
Qu, XJ1
Yu, Y1
Kohn, EC1
Friedlander, ML1
Lenders, JW1
Sluiter, HE1
Thien, T1
Willemsen, J1

Other Studies

2 other studies available for nifedipine and Bladder Cancer

ArticleYear
Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
    International journal of cancer, 2008, Jul-15, Volume: 123, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Calcium Channel Blockers; Cell Cycle; Cell Line, Tumor; Chromosome

2008
Treatment of a phaeochromocytoma of the urinary bladder with nifedipine.
    British medical journal (Clinical research ed.), 1985, Jun-01, Volume: 290, Issue:6482

    Topics: Adult; Female; Humans; Hypertension; Nifedipine; Pheochromocytoma; Urinary Bladder Neoplasms

1985